About Us
About Carna
Management
Our Business
Products & Services
Products
Kinase Proteins and Other Protein Products
Assay Kits
Services
Activity-based Biochemical Screening/Profiling Assay Services
Cell-based Assay Services
Pricing & Technical Inquiry
Drug Discovery
Pipeline
Science
Technology
Partnering
Investors
News
Financial Reports/Presentations
Financial Highlights
IR Schedule
IR Contact
JP
EN
JP
EN
IR News
Investors
Investors
2016 IR News
IR News 2016
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Dec 16, 2016
FINANCIALS
Revision of Results Forecast for the Fiscal Year Ending December 31, 2016
Nov 07, 2016
FINANCIALS
Financial Results FY2016 Q3
Nov 07, 2016
FINANCIALS
Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2016
Aug 26, 2016
ANNOUNCEMENT
Discovery of a novel Wnt inhibitor with potential to eradicate colorectal cancer stem cells
Aug 05, 2016
FINANCIALS
Consolidated Financial Results for the Second Quarter of the Year Ending December 31, 2016
Aug 05, 2016
ANNOUNCEMENT
Carna Biosciences Announces Termination of Collaboration with Johnson & Johnson Innovation
May 27, 2016
ANNOUNCEMENT
ProNAi Licenses Cancer Drug Candidate Targeting CDC7 from Carna Biosciences
May 09, 2016
FINANCIALS
Consolidated Financial Results for the First Quarter of the Year Ending December 31, 2016
Apr 18, 2016
NEWS
Research Report by FISCO Ltd.
Feb 12, 2016
FINANCIALS
Consolidated Financial Results for the Year Ended December 31, 2015
Feb 12, 2016
ANNOUNCEMENT
Carna Biosciences Announces Opening of San Francisco Research Center
No IR News.
Investors Menu
News
Financial Reports/
Presentations
Financial Reports/
Presentations
Financial Highlights
IR Schedule
Contact IR
IR Contact
Email Alerts